 | • レポートコード：C9J07955 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥444,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥562,400 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥740,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国における移行上皮癌治療薬市場について調査・分析したレポートで、移行上皮癌治療薬の世界市場動向、市場規模、主要企業情報などが含まれています。移行上皮癌治療薬の種類別には、膀胱腫瘍経尿道的切除、膀胱摘除術、尿路変更術に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・移行上皮癌治療薬産業の概要 ・移行上皮癌治療薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国の移行上皮癌治療薬市場 2014年-2019年 ・世界及び中国の移行上皮癌治療薬市場現状 ・企業別分析：AstraZeneca, Roche, Bristol-Myers Squibb, Pfizer, Exelixis, Eisai, Merck, Eli Lilly, Celgeneなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：膀胱腫瘍経尿道的切除、膀胱摘除術、尿路変更術 ・世界及び中国の移行上皮癌治療薬市場予測 2019年-2024年 ・移行上皮癌治療薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国の移行上皮癌治療薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Transitional Cell Cancer Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Transitional Cell Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Transitional Cell Cancer Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Transitional Cell Cancer Therapeutics market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Transitional Cell Cancer Therapeutics industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Transitional Cell Cancer Therapeutics industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Transitional Cell Cancer Therapeutics Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Transitional Cell Cancer Therapeutics as well as some small players. At least 9 companies are included:
* AstraZeneca
* Roche
* Bristol-Myers Squibb
* Pfizer
* Exelixis
* Eisai
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Transitional Cell Cancer Therapeutics market in gloabal and china.
* Transurethral Resection Of Bladder Tumor
* Cystectomy
* Urinary Diversion
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospital
* Cancer Research Institutes
* Multispecialty Clinics
* Ambulatory Surgical Centers
Reasons to Purchase this Report:
* Estimates 2019-2024 Transitional Cell Cancer Therapeutics market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Transitional Cell Cancer Therapeutics Industry
1.1 Brief Introduction of Transitional Cell Cancer Therapeutics
1.2 Development of Transitional Cell Cancer Therapeutics Industry
1.3 Status of Transitional Cell Cancer Therapeutics Industry
Chapter Two Manufacturing Technology of Transitional Cell Cancer Therapeutics
2.1 Development of Transitional Cell Cancer Therapeutics Manufacturing Technology
2.2 Analysis of Transitional Cell Cancer Therapeutics Manufacturing Technology
2.3 Trends of Transitional Cell Cancer Therapeutics Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Roche
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Bristol-Myers Squibb
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Pfizer
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Exelixis
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Eisai
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Merck
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Transitional Cell Cancer Therapeutics
4.1 2014-2019 Global Capacity, Production and Production Value of Transitional Cell Cancer Therapeutics Industry
4.2 2014-2019 Global Cost and Profit of Transitional Cell Cancer Therapeutics Industry
4.3 Market Comparison of Global and Chinese Transitional Cell Cancer Therapeutics Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Transitional Cell Cancer Therapeutics
4.5 2014-2019 Chinese Import and Export of Transitional Cell Cancer Therapeutics
Chapter Five Market Status of Transitional Cell Cancer Therapeutics Industry
5.1 Market Competition of Transitional Cell Cancer Therapeutics Industry by Company
5.2 Market Competition of Transitional Cell Cancer Therapeutics Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Transitional Cell Cancer Therapeutics Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Transitional Cell Cancer Therapeutics Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Transitional Cell Cancer Therapeutics
6.2 2019-2024 Transitional Cell Cancer Therapeutics Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Transitional Cell Cancer Therapeutics
6.4 2019-2024 Global and Chinese Supply and Consumption of Transitional Cell Cancer Therapeutics
6.5 2019-2024 Chinese Import and Export of Transitional Cell Cancer Therapeutics
Chapter Seven Analysis of Transitional Cell Cancer Therapeutics Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Transitional Cell Cancer Therapeutics Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Transitional Cell Cancer Therapeutics Industry
Chapter Nine Market Dynamics of Transitional Cell Cancer Therapeutics Industry
9.1 Transitional Cell Cancer Therapeutics Industry News
9.2 Transitional Cell Cancer Therapeutics Industry Development Challenges
9.3 Transitional Cell Cancer Therapeutics Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Transitional Cell Cancer Therapeutics Industry
Tables and Figures
Figure Transitional Cell Cancer Therapeutics Product Picture
Table Development of Transitional Cell Cancer Therapeutics Manufacturing Technology
Figure Manufacturing Process of Transitional Cell Cancer Therapeutics
Table Trends of Transitional Cell Cancer Therapeutics Manufacturing Technology
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
Figure Transitional Cell Cancer Therapeutics Product and Specifications
Table 2014-2019 Transitional Cell Cancer Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Transitional Cell Cancer Therapeutics Production Global Market Share
……
……
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Capacity List
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Manufacturers Capacity Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Manufacturers Capacity Share
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production List
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Manufacturers Production Share
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production Value List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Production Value and Growth Rate
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production Value Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Manufacturers Production Value Share
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Transitional Cell Cancer Therapeutics Production
Table 2014-2019 Global Supply and Consumption of Transitional Cell Cancer Therapeutics
Table 2014-2019 Import and Export of Transitional Cell Cancer Therapeutics
Figure 2018 Global Transitional Cell Cancer Therapeutics Key Manufacturers Capacity Market Share
Figure 2018 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production Market Share
Figure 2018 Global Transitional Cell Cancer Therapeutics Key Manufacturers Production Value Market Share
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Capacity List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Capacity
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Capacity Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Capacity Share
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Production List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Production
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Production Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Production Share
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Consumption Volume List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Consumption Volume
Table 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Consumption Volume Share List
Figure 2014-2019 Global Transitional Cell Cancer Therapeutics Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Transitional Cell Cancer Therapeutics Consumption Volume Market by Application
Table 89 2014-2019 Global Transitional Cell Cancer Therapeutics Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Transitional Cell Cancer Therapeutics Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Transitional Cell Cancer Therapeutics Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Transitional Cell Cancer Therapeutics Consumption Volume Market by Application
Figure 2019-2024 Global Transitional Cell Cancer Therapeutics Capacity Production and Growth Rate
Figure 2019-2024 Global Transitional Cell Cancer Therapeutics Production Value and Growth Rate
Table 2019-2024 Global Transitional Cell Cancer Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Transitional Cell Cancer Therapeutics Production
Table 2019-2024 Global Supply and Consumption of Transitional Cell Cancer Therapeutics
Table 2019-2024 Import and Export of Transitional Cell Cancer Therapeutics
Figure Industry Chain Structure of Transitional Cell Cancer Therapeutics Industry
Figure Production Cost Analysis of Transitional Cell Cancer Therapeutics
Figure Downstream Analysis of Transitional Cell Cancer Therapeutics
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Transitional Cell Cancer Therapeutics Industry
Table Transitional Cell Cancer Therapeutics Industry Development Challenges
Table Transitional Cell Cancer Therapeutics Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Transitional Cell Cancer Therapeuticss Project Feasibility Study
世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…- 世界の樹状細胞がんワクチン市場：市場規模・現状・予測 Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine…
- 世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…
- 世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …
- 世界の腎臓がん市場：市場規模・現状・予測 Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatm…